ONEM
|
1Life Healthcare, Inc.
|
0.04%
|
US
|
NASDAQ
|
NUVA
|
NuVasive, Inc.
|
0.04%
|
US
|
NASDAQ
|
NEOG
|
Neogen Corporation
|
0.04%
|
US
|
NASDAQ
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
0.04%
|
US
|
NASDAQ
|
FATE
|
Fate Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
ENOV
|
Enovis Corporation
|
0.04%
|
US
|
NYSE
|
BEAM
|
Beam Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|
EMBC
|
Embecta Corp.
|
0.03%
|
US
|
NASDAQ
|
CVET
|
Covetrus, Inc.
|
0.03%
|
US
|
NASDAQ
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.03%
|
US
|
NASDAQ
|
VIR
|
Vir Biotechnology, Inc.
|
0.03%
|
US
|
NASDAQ
|
SHC
|
Sotera Health Company
|
0.03%
|
US
|
NASDAQ
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.02%
|
US
|
NASDAQ
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
NEO
|
NeoGenomics, Inc.
|
0.02%
|
US
|
NASDAQ
|
EBS
|
Emergent Biosolutions, Inc.
|
0.02%
|
US
|
NYSE
|
AGL
|
agilon health, inc.
|
0.02%
|
US
|
NYSE
|
ZIMV
|
ZimVie Inc.
|
0.01%
|
US
|
NASDAQ
|
SGFY
|
Signify Health, Inc.
|
0.01%
|
US
|
NYSE
|
NVTA
|
Invitae Corporation
|
0.01%
|
US
|
NYSE
|